Clinical Trial

ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy

Study acronym: ART
Recruiting
View on ClinicalTrials.gov →
Summary
The overall purpose of ART trial is to establish the Safety and Efficacy of the J-VALVE Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients with Grade≥3+ Native Aortic Regurgitation.
Protocol Amendment History 2 changes
notable Trial sites expanded: 12 -> 28 locations 2026-08-13
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT07453407
Lead Sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine
Conditions Aortic Regurgitation, Aortic Valve Insufficiency, Aortic Insufficiency
Enrollment 1,250 participants
Start Date 2026-03-05
Primary Completion 2029-03 (estimated)
Study Completion 2038-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-12